These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 6319678
1. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide. Smith MM, Harden TK. J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678 [Abstract] [Full Text] [Related]
2. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation. Noronha-Blob L, Lowe VC, Kinnier WJ, U'Prichard DC. Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808 [Abstract] [Full Text] [Related]
3. Muscarinic receptor regulation of NG108-15 adenylate cyclase: requirement for Na+ and GTP. Lichtshtein D, Boone G, Blume A. J Cyclic Nucleotide Res; 1979 Oct; 5(5):367-75. PubMed ID: 521545 [Abstract] [Full Text] [Related]
4. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes. Costa T, Klinz FJ, Vachon L, Herz A. Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042 [Abstract] [Full Text] [Related]
5. Receptor-mediated inhibitions of NG108-15 adenylate cyclase: essential role of Na+ and GTP. Blume AJ, Lichtshtein D, Boone G. Adv Biochem Psychopharmacol; 1980 Dec; 21():339-48. PubMed ID: 6246750 [No Abstract] [Full Text] [Related]
6. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Law PY, Hom DS, Loh HH. Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114 [Abstract] [Full Text] [Related]
7. Coupling of prostaglandin E1 receptors to the stimulatory GTP-binding protein Gs is enhanced in neuroblastoma x glioma (NG108-15) hybrid cells chronically exposed to an opioid. Ammer H, Schulz R. Mol Pharmacol; 1993 Apr; 43(4):556-63. PubMed ID: 8386308 [Abstract] [Full Text] [Related]
8. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors. Graeser D, Neubig RR. Mol Pharmacol; 1993 Mar; 43(3):434-43. PubMed ID: 8095695 [Abstract] [Full Text] [Related]
9. Agonist-induced down-regulation of muscarinic cholinergic and alpha 2-adrenergic receptors after inactivation of Ni by pertussis toxin. Thomas JM, Hoffman BB. Endocrinology; 1986 Sep; 119(3):1305-14. PubMed ID: 2426098 [Abstract] [Full Text] [Related]
11. Uncoupling of alpha-adrenoceptor-mediated inhibition of human platelet adenylate cyclase by N-ethylmaleimide. Jakobs KH, Lasch P, Minuth M, Aktories K, Schultz G. J Biol Chem; 1982 Mar 25; 257(6):2829-33. PubMed ID: 6277915 [Abstract] [Full Text] [Related]
12. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine. Woodcock EA, Johnston CI. Mol Pharmacol; 1982 Nov 25; 22(3):589-94. PubMed ID: 6296653 [Abstract] [Full Text] [Related]
13. Guanine nucleotide binding sites, responsible for adenylate cyclase activation and carbamylcholine binding inhibition, show similar properties in rat heart membranes. Waelbroeck M, Robberecht P, Chatelain P, Christophe J. J Cyclic Nucleotide Res; 1981 Nov 25; 7(3):173-85. PubMed ID: 7287969 [Abstract] [Full Text] [Related]
14. Differential roles of high and low affinity guanosine 5'-triphosphate binding sites in the regulation of follicle-stimulating hormone binding to receptor and signal transduction in bovine calf testis membranes. Zhang SB, Dattatreyamurty B, Reichert LE. Endocrinology; 1991 Jan 25; 128(1):295-302. PubMed ID: 1898882 [Abstract] [Full Text] [Related]
15. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase. Motulsky HJ, Shattil SJ, Ferry N, Rozansky D, Insel PA. Mol Pharmacol; 1986 Jan 25; 29(1):1-6. PubMed ID: 2418346 [Abstract] [Full Text] [Related]
16. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation. Law PY, Bergsbaken C. J Pharmacol Exp Ther; 1995 Jan 25; 272(1):322-32. PubMed ID: 7815347 [Abstract] [Full Text] [Related]
17. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins. Prather PL, Loh HH, Law PY. Mol Pharmacol; 1994 May 25; 45(5):997-1003. PubMed ID: 8190115 [Abstract] [Full Text] [Related]
18. In vitro effect of chlorpyrifos oxon on muscarinic receptors and adenylate cyclase. Huff RA, Abou-Donia MB. Neurotoxicology; 1995 May 25; 16(2):281-90. PubMed ID: 7566687 [Abstract] [Full Text] [Related]
19. Heterologous up-regulation of Ni-coupled receptors in cultured neural hybrid cells by a transferable factor, whose expression is inhibited in a cyclic AMP-dependent, cell-specific manner. Noronha-Blob L, Lowe VC, Kinnier WJ, U'Prichard DC. Mol Pharmacol; 1987 Nov 25; 32(5):669-77. PubMed ID: 2824982 [Abstract] [Full Text] [Related]
20. Further evidence that muscarinic cholinergic receptors of 1321N1 astrocytoma cells couple to a guanine nucleotide regulatory protein that is not Ni. Martin MW, Evans T, Harden TK. Biochem J; 1985 Jul 15; 229(2):539-44. PubMed ID: 3929772 [Abstract] [Full Text] [Related] Page: [Next] [New Search]